Expanding the horizons of lipidomics. Towards fluxolipidomics

Molecular Membrane Biology

Volumn 29, Issue 7, 2012, Pages 222-228

  Lagarde, Michel ^a   Bernoud Hubac, Nathalie ^a   Guichardant, Michel ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Lipid biochemistry; Lipid peroxidation; Mass spectrometry; Membrane lipid

Indexed keywords

ESSENTIAL FATTY ACID; FLUORESCENT DYE; MEMBRANE LIPID; POLYUNSATURATED FATTY ACID;

DEGRADATION; FATTY ACID DESATURATION; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FLUXOLIPIDOMICS; HUMAN; LIPID COMPOSITION; LIPID METABOLISM; LIPIDOMICS; MASS SPECTROMETRY; MEMBRANE STRUCTURE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; HUMANS; LIPID METABOLISM; LIPID PEROXIDATION; METABOLOMICS;

EID: 84867962537     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.3109/09687688.2012.689378     Document Type: Review

References (70)

1. Agbaga MP, Mandal MN, Anderson RE. 2010. Retinal very long-chain PUFAs: New insights from studies on ELOVL4 protein. J Lipid Res 51:1624-1642.
2. Andreyev AY, Fahy E, Guan Z, Kelly S, Li X, McDonald JG, et al. 2010. Subcellular organelle lipidomics in TLR-4-activated macrophages. J Lipid Res 51:2785-2797.
3. Ariola FS, Mudaliar DJ, Walvick RP, Heikal AA. 2006. Dynamics imaging of lipid phases and lipid-marker interactions in model biomembranes. Phys Chem Chem Phys 8:4517-4529.
4. Balogh G, Péter M, Liebisch G, Horváth I, Török Z, Nagy E, et al. 2010. Lipidomics reveals membrane lipid remodelling and release of potential lipid mediators during early stress responses in a murine melanoma cell line. Biochim Biophys Acta 1801:1036-1047.
5. Bisogno T, Delton-Vandenbroucke I, Milone A, Lagarde M, Di Marzo V. 1999. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Arch Biochem Biophys 370:300-307. (Pubitemid 29491438)
6. Burdge G. 2004. Alpha-linolenic acid metabolism in men and women: Nutritional and biological implications. Curr Opin Clin Nutr Metab Care 7:137-144. (Pubitemid 40340675)
7. Caesar R, Manieri M, Kelder T, Boekschoten M, Evelo C, Müller M, et al. 2010. A combined transcriptomics and lipidomics analysis of subcutaneous, epididymal and mesenteric adipose tissue reveals marked functional differences. PLoS One 5:e11525.
8. Capdevila JH, Falck JR, Harris RC. 2000. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J Lipid Res 41:163-181. (Pubitemid 30117856)
9. Cascante M, Marin S. 2008. Metabolomics and fluxomics approaches. Essays Biochem 45:67-81.
10. Chen P, Véricel E, Lagarde M, Guichardant M. 2011. Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation. FASEB J 25:382-388.
11. da Veiga MA, Fonseca Bloise F, Costa-E-Sousa RH, Souza LL, Almeida NA, Oliveira KJ, et al. 2008. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion. J Endocrinol 199:235-242.
12. Diczfalusy U. 1994. Beta-oxidation of eicosanoids. Prog Lipid Res 33:403-428. (Pubitemid 2119693)
13. Ensor CM, Tai HH. 1995. 15-Hydroxyprostaglandin dehydrogenase. J Lipid Mediat Cell Signal 12:313-319.
14. Fleming I. 2011. Cytochrome P450-dependent eicosanoid production and crosstalk. Curr Opin Lipidol 22:403-409.
15. Goto-Inoue N, Hayasaka T, Zaima N, Setou M. 2011. Imaging mass spectrometry for lipidomics. Biochim Biophys Acta 1811:961-969.
16. Gross RW, Han X. 2011. Lipidomics at the interface of structure and function in systems biology. Chem Biol 18:284-291.
17. Gross RW, Jenkins CM, Yang J, Mancuso DJ, Han X. 2005. Functional lipidomics: The roles of specialized lipids and lipid-protein interactions in modulating neuronal function. Prostaglandins Other Lipid Mediat 77:52-64; Review. (Pubitemid 41133415)
18. Guichardant M, Chen P, Liu M, Calzada C, Colas R, Véricel E, et al. 2011. Functional lipidomics of oxidized products from polyunsaturated fatty acids. Chem Phys Lipids 164:544-548; Review.
19. Guillemin Y, Lopez J, Gimenez D, Fuertes G, Valero JG, Blum L, et al. 2010. Active fragments from pro-and antiapoptotic BCL-2 proteins have distinct membrane behavior reflecting their functional divergence. PLoS One 5:e9066.
20. Gupta S, Maurya MR, Stephens DL, Dennis EA, Subramaniam S. 2009. An integrated model of eicosanoid metabolism and signaling based on lipidomics flux analysis. Biophys J 96:4542-4551.
21. Hammarström S, Orning L, Bergström K. 1985. Metabolism of leukotrienes. Mol Cell Biochem 69:7-16. (Pubitemid 16219782)
22. Han X, Gross RW. 2003. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: A bridge to lipidomics. J Lipid Res 44:1071-1109.
23. Hellerer T, Axäng C, Brackmann C, Hillertz P, Pilon M, Enejder A. 2007. Monitoring of lipid storage in Caenorhabditis elegans using coherent anti-Stokes Raman scattering (CARS) microscopy. Proc Natl Acad Sci USA 104:14658-14663. (Pubitemid 350003199)
24. Hu C, Hoene M, Zhao X, Häring HU, Schleicher E, Lehmann R, et al. 2010. Lipidomics analysis reveals efficient storage of hepatic triacylglycerides enriched in unsaturated fatty acids after one bout of exercise in mice. PLos One 5:e13318.
25. Hussein N, Ah-Sing E, Wilkinson P, Leach C, Griffin BA, Millward DJ. 2005. Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res 46:269-280. (Pubitemid 40271091)
26. Imai Y, Uno T, Nakamura M, Yokota H. 1989. Structure-function relationships of cytochrome P-450 laurate (omega-1)-hydroxylase. Drug Metab Rev 20:467-478. (Pubitemid 19277711)
27. Imig JD. 2005. Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases.AmJ Physiol Renal Physiol 289:F496-F503. (Pubitemid 41208461)
28. Ishitsuka R, Yamaji-Hasegawa A, Makino A, Hirabayashi Y, Kobayashi T. 2004. A lipid-specific toxin reveals heterogeneity of sphingomyelin-containing membranes. Biophys J 86:296-307. (Pubitemid 38067457)
29. Isobe Y, Arita M, Matsueda S, Iwamoto R, Fujihara T, Nakanishi H, et al. 2012. Identification and structure determination of novel anti-inflammatory mediator Resolvin E3, 17,18-Dihydroxyeicosapentaenoic acid. J Biol Chem 287: 10525-10534.
30. Khatchadourian A, Krumova K, Boridy S, Ngo AT, Maysinger D, Cosa G. 2009. Molecular imaging of lipid peroxyl radicals in living cells with a BODIPY-alpha-tocopherol adduct. Biochemistry 48:5658-5668.
31. Kim HY, Spector AA, Xiong ZM. 2011. A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. Prostaglandins Other Lipid Mediat 96:114-120.
32. Kiyokawa E, Baba T, Otsuka N, Makino A, Ohno S, Kobayashi T. 2005. Spatial and functional heterogeneity of sphingolipid-rich membrane domains. J Biol Chem 280: 24072-24084. (Pubitemid 40884895)
33. Lagarde M. 1988. Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function. Prog Lipid Res 27:135-152.
34. Lagarde M, Géloën A, Record M, Vance D, Spener F. 2003. Lipidomics is emerging. Biochim Biophys Acta 1634:61. (Pubitemid 37487709)
35. Lagarde M, Gualde N, Rigaud M. 1989. Metabolic interactions between eicosanoids in blood and vascular cells. Biochem J 257:313-320. (Pubitemid 19040899)
36. Leidl K, Liebisch G, Richter D, Schmitz G. 2008. Mass spectrometric analysis of lipid species of human circulating blood cells. Biochim Biophys Acta 1781:655-664.
37. Lim RS, Kratzer A, Barry NP, Miyazaki-Anzai S, Miyazaki M, Mantulin WW, et al. 2010. Multimodal CARS microscopy determination of the impact of diet on macrophage infiltration and lipid accumulation on plaque formation in ApoE-deficient mice. J Lipid Res 51:1729-1737.
38. Murphy RC, Hankin JA, Barkley RM. 2009. Imaging of lipid species by MALDI mass spectrometry. J Lipid Res 50: S317-S322.
39. Na HK, Park JM, Lee HG, Lee HN, Myung SJ, Surh YJ. 2011. 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy. Biochem Pharmacol 82:1352-1360.
40. Nicolaou A, Masoodi M, Mir A. 2009. Lipidomic analysis of prostanoids by liquid chromatography-electrospray tandem mass spectrometry. Methods Mol Biol 579:271-286.
41. Pezacki JP, Blake JA, Danielson DC, Kennedy DC, Lyn RK, Singaravelu R. 2011. Chemical contrast for imaging living systems: Molecular vibrations drive CARS microscopy. Nat Chem Biol 7:137-145.
42. Pfister SL, Gauthier KM, Campbell WB. 2010. Vascular pharmacology of epoxyeicosatrienoic acids. Adv Pharmacol 60:27-59.
43. Piomelli D, Astarita G, Rapaka R. 2007. A neuroscientist's guide to lipidomics. Nat Rev Neurosci 8:743-754. (Pubitemid 47462119)
44. Poulos A. 1995. Very long chain fatty acids in higher animals-a review. Lipids 30:1-14.
45. Powell WS, Rokach J. 2005. Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE. Prog Lipid Res 44:154-183. (Pubitemid 40733083)
46. Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH, et al. 2010. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res 51:3299-3305.
47. Reeder SB, Cruite I, Hamilton G, Sirlin CB. 2011. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34:729-749.
48. Samuelsson B. 1978. Prostaglandins and thromboxanes. Recent Prog Horm Res 34:239-258. (Pubitemid 9179245)
49. Samuelsson B. 1986. Leukotrienes and other lipoxygenase products. Prog Lipid Res 25:13-18.
50. Shevchenko A, Simons K. 2010. Lipidomics: Coming to grips with lipid diversity. Nat Rev Mol Cell Biol 11:593-598.
51. Schmelzer K, Fahy E, Subramaniam S, Dennis EA. 2007. The lipid maps initiative in lipidomics. Methods Enzymol 432:171-183.
52. Serhan CN. 2009. Systems approach to inflammation resolution: Identification of novel anti-inflammatory and pro-resolving mediators. J Thromb Haemost 7(Suppl 1):44-48.
53. Serhan CN, Chiang N, Van Dyke TE. 2008. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349-361. (Pubitemid 351595216)
54. Serhan CN, Lu Y, Hong S, Yang R. 2007. Mediator lipidomics: Search algorithms for eicosanoids, resolvins, and protectins. Methods Enzymol 432:275-317.
55. Smith WL. 2008. Nutritionally essential fatty acids and biologically indispensable cyclooxygenases. Trends Biochem Sci 33:27-37.
56. Spandl J, White DJ, Peychl J, Thiele C. 2009. Live cell multicolor imaging of lipid droplets with a new dye, LD540. Traffic 10:1579-1584.
57. Sparvero LJ, Amoscato AA, Kochanek PM, Pitt BR, Kagan VE, Bayir H. 2010. Mass-spectrometry based oxidative lipidomics and lipid imaging: Applications in traumatic brain injury. J Neurochem 115:1322-1336.
58. Spector AA. 2009. Arachidonic acid cytochrome P450 epoxygenase pathway. J Lipid Res 50:S52-S56.
59. Spector AA, Gordon JA, Moore SA. 1994. Beta-oxidation of hydroxyeicosatetraenoic acids: A peroxisomal process. World Rev Nutr Diet 75:8-15.
60. Spector AA, Norris AW. 2007. Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol 292: C996-C1012. (Pubitemid 46442641)
61. Spener F, Lagarde M, Geloen A, Record M. 2003. What is lipidomics? Eur J Lipid Sci Technol 105:481-482.
62. Song WL, Wang M, Ricciotti E, Fries S, Yu Y, Grosser T, et al. 2008. Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans. J Biol Chem 283:1179-1188.
63. Sun YX, Tsuboi K, Okamoto Y, Tonai T, Murakami M, Kudo I, et al. 2004. Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. Biochem J 380:749-756. (Pubitemid 38850516)
64. Tai HH, Cho H, Tong M, Ding Y. 2006. NAD+-linked 15-hydroxyprostaglandin dehydrogenase: Structure and biological functions. Curr Pharm Des 12:955-962.
65. Touboul D, Laprévote O, Brunelle A. 2011. Micrometric molecular histology of lipids by mass spectrometry imaging. Curr Opin Chem Biol;15;725-732.
66. Vellani V, Petrosino S, De Petrocellis L, Valenti M, Prandini M, Magherini PC, et al. 2008. Functional lipidomics. Calciumindependent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin. Neuropharmacology 55:1274-1279.
67. Welti R, Shah J, Li W, Li M, Chen J, Burke JJ, et al. 2007. Plant lipidomics:Discerning biological function by profiling plant complex lipids using mass spectrometry. Front Biosci 12:2494-2506.
68. Wilkinson SG. 1996. Bacterial lipopolysaccharides-themes and variations. Prog Lipid Res 35:283-343.
69. Wüstner D, Solanko L, Sokol E, Garvik O, Li Z, Bittman R, et al. 2011. Quantitative assessment of sterol traffic in living cells by dual labeling with dehydroergosterol and BODIPY-cholesterol. Chem Phys Lipids 164:221-235.
70. Yang W, Ni J, Woodward DF, Tang-Liu DD, Ling KH. 2005. Enzymatic formation of prostamide F2alpha from anandamide involves a newly identified intermediate metabolite, prostamide H2. J Lipid Res 46:2745-2751. (Pubitemid 43107487)